Option and License AgreementLicense Agreement • February 25th, 2016 • Cempra, Inc. • Pharmaceutical preparations • Delaware
This Option and License Agreement (the “Agreement”) is entered into as of January 29, 2016 (the “Effective Date”) by and between Cempra Pharmaceuticals, Inc., a Delaware corporation having an address at 6320 Quadrangle Dr. #360, Chapel Hill, NC 27517 (“Cempra”), and Macrolide Pharmaceuticals, Inc., a Delaware corporation having an address at 480 Arsenal St., Suite 130, Watertown, MA 02472 (“MP”). MP and Cempra may be referred to herein individually as a “Party” or collectively, as the “Parties.”
API MANUFACTURING AND SUPPLY AGREEMENTSupply Agreement • February 25th, 2016 • Cempra, Inc. • Pharmaceutical preparations • New York
This API Manufacturing and Supply Agreement (the “Agreement”) is entered into as of ________, 2015 (the “Effective Date”) by and between Cempra Pharmaceuticals, Inc., a company organized under the laws of Delaware, USA with a place of business at 6340 Quadrangle Drive, Suite 100, Chapel Hill, NC 27517, USA (“Cempra”), and FUJIFILM Finechemicals Co., Ltd., a company organized under the laws of Japan with a place of business at 2-3, Higashiyawata 5-chome, Hiratsuka, Kanagawa 254-0016, Japan (“FFFC”). Cempra and FFFC may be referred to herein individually as a “Party”, and collectively as the “Parties”.
